To hear about similar clinical trials, please enter your email below
Trial Title:
Main Postoperative Complications After COVID-19
NCT ID:
NCT05694949
Condition:
Intestines Cancer
Pulmonary Cancer
Liver Cancer
Trauma
Fractures, Bone
Conditions: Official terms:
Intestinal Neoplasms
Lung Neoplasms
Postoperative Complications
Fractures, Bone
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
To explore the relationship between SARS-CoV-2 infection in different time before
operation and postoperative main complications (mortality, main pulmonary and
cardiovascular complications) 30 days after operation; To determine the best timing of
surgery after SARS-CoV-2 infection.
Criteria for eligibility:
Study pop:
Adult patients having elective or confine surgery in operating room
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Ageā„18 years;
- Patients undergoing any type of elective or confine surgery in operating room;
- Informed consent.
Exclusion Criteria:
- Surgery under local anesthesia (without participation of anesthetist)
- Surgery outside the operating room, such as gastrointestinal endoscopy, puncture
biopsy, etc
- Patients who cannot determine whether they have had SARS CoV-2 infection before
surgery
- Participating in conflicting clinical study
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
February 1, 2023
Completion date:
February 1, 2024
Lead sponsor:
Agency:
RenJi Hospital
Agency class:
Other
Collaborator:
Agency:
The First Affiliated Hospital of Anhui Medical University
Agency class:
Other
Collaborator:
Agency:
First Affiliated Hospital of Chongqing Medical University
Agency class:
Other
Collaborator:
Agency:
Sichuan Academy of Medical Sciences
Agency class:
Other
Collaborator:
Agency:
Second Hospital of Shanxi Medical University
Agency class:
Other
Source:
RenJi Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05694949
